Carregant...

An Update on Pharmacological, Pharmacokinetic Properties and Drug–Drug Interactions of Rotigotine Transdermal System in Parkinson’s Disease and Restless Legs Syndrome

This narrative review reports on the pharmacological and pharmacokinetic properties of rotigotine, a non-ergolinic D(3)/D(2)/D(1) dopamine receptor agonist approved for the treatment of early- and advanced-stage Parkinson’s disease (PD) and moderate to severe restless legs syndrome (RLS). Rotigotine...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drugs
Autors principals: Elshoff, Jan-Peer, Cawello, Willi, Andreas, Jens-Otto, Mathy, Francois-Xavier, Braun, Marina
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4382528/
https://ncbi.nlm.nih.gov/pubmed/25795100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-015-0377-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!